1998
DOI: 10.1007/bf03038497
|View full text |Cite
|
Sign up to set email alerts
|

Prophylaxe und Therapie akuter Strahlenfolgen an Haut und Schleimhaut

Abstract: The management of the acute radiation related morbidity has a wide clinical spectrum among different radiation therapy centers. Systematic prospectively designed investigations are necessary in order to achieve a further reduction in the radiation related acute morbidity. Therefore, a multicenter collaborative working group has been founded.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
9
0
5

Year Published

1998
1998
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 12 publications
2
9
0
5
Order By: Relevance
“…The Consensus Development Panel of the National Institutes of Health (Consensus statement, 1990) stated that no drugs can prevent mucositis, an opinion that still holds true to date (Scully and Epstein, 1996;Zimmermann et al, 1998;Karthaus et al, 1999;Plevovà,1999;Sonis et al, 1999;Sutherland and Browman, 2001). Consequently, prevention of mucositis is still limited to reduction of its severity by oral care programs, relief of pain and discomfort, and/or strategies to eliminate micro-organisms that are thought to be involved in the development or promotion of radiation mucositis.…”
Section: Mucositismentioning
confidence: 99%
See 1 more Smart Citation
“…The Consensus Development Panel of the National Institutes of Health (Consensus statement, 1990) stated that no drugs can prevent mucositis, an opinion that still holds true to date (Scully and Epstein, 1996;Zimmermann et al, 1998;Karthaus et al, 1999;Plevovà,1999;Sonis et al, 1999;Sutherland and Browman, 2001). Consequently, prevention of mucositis is still limited to reduction of its severity by oral care programs, relief of pain and discomfort, and/or strategies to eliminate micro-organisms that are thought to be involved in the development or promotion of radiation mucositis.…”
Section: Mucositismentioning
confidence: 99%
“…Currently, most oral care programs aim at: removal of mucosal-irritating factors, cleansing of the oral mucosa, maintaining the moisture of the lips and the oral cavity, relief of mucosal pain and inflammation, and prevention or treatment of infection (Miaskowski, 1990;Scully and Epstein, 1996;Zimmermann et al, 1998). Although it has been suggested that good oral hygiene may reduce the development and severity of mucositis, no controlled studies of large numbers of patients have yet been undertaken.…”
Section: Mucositismentioning
confidence: 99%
“…As progress has been made in understanding the pathophysiology of RIF lesions, different treatment strategies have been developed in clinical practice. These consist of anti‐oxidants (vitamin‐E [13], superoxide dismutase [14]), angiotensin‐converting enzyme inhibitor (Captopril [14]), interferon‐gamma [15], anti‐inflammatory agents (Brufen [16]) and Pentoxifylline (Trental) [17]. However, all the studies of these strategies were performed in patients with acute radiation morbidity and the results, if any, were short‐lived [13].…”
Section: Discussionmentioning
confidence: 99%
“…The acute and late radiation related morbidity influences the patients quality of life in radiotherapy and it is hard to treat [1]. It is possible, that the difference in the intrinsic radio-sensitivity predisposes individuals to develop more severe side effects.…”
Section: Introductionmentioning
confidence: 99%